Home | Publications | Animal / Veterinary place holder
place holder place holder

Animal / Veterinary


Animal Biotechnology

Technologies, Markets and Companies

Publication Date   September 2008
Publisher   Jain PharmaBiotech
Product Type   Report
Pages   323
ISBN Number   not applicable
Product Code   JAI029
Ask a question about this product?

Price £900.00

approximately: $1,342 | €1,072

Summary


This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage genetic disorders and improve animal breeding. Genomics, proteomics and bioinformatics are also being applied to animal biotechnology.

Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.

Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicine

Molecular diagnosis is assuming an important place in veterinary practice. Polymerase chain reaction and its modifications are considered to be important. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely used. Newer biochip-based technologies and biosensors are also finding their way in veterinary diagnostics.

Biotechnology products are approved by the Center for Veterinary Medicine of the FDA. Regulatory issues relevant to animal biotechnology are described.

Approximately 108 companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnology companies.Information is given about the research activities of 11 veterinary and livestock research institutes. Important 109 collaborations in this area are shown.

Share of biotechnology-based products and services in 2007 is analyzed and the market is projected to 2017.

The text is supplemented with 33 tables and five figures.Selected 250 references from the literature are appended.

Content


  • Executive Summary
  • 1. Introduction to Animal Biotechnology
    • Introduction
    • Historical evolution of animal biotechnology
    • Basics of biotechnology
      • DNA
      • RNA
      • Genes
      • Single nucleotide polymorphisms
      • Gene expression
      • Gene regulation
      • Proteins
      • Functions of proteins
      • Monoclonal antibodies
    • Animal genetics
      • Molecular genetics
      • Twinning in cattle
      • Pig genetics
      • Genetic studies in dogs
    • Animal genomics
      • The mouse genome
      • The dog genome
      • The cat genome
      • Marsupial genomes
      • Genomes of non-human primates
      • Chimpanzee genome
      • Genome of the rhesus macaque
      • Livestock genomics
      • Bovine genome
      • Bovine SNP map
      • Pig genome
      • Horse genomics
      • Sheep genome
      • Chicken genome
      • Priority genome list of the National Human Genome Research Institute
      • Applications of animal genomics
      • Genomics of disease resistance
      • Statistical genomics to improve breeding
    • Animal proteomics
      • Applications of proteomics in animals
      • Caseins in goat milk
      • Lactic acid bacteria
      • Applications of proteomics in animal healthcare
    • Bioinformatics
    • Application of nanobiotechnology for animal health
    • Recombinant protein manufacture
    • Animal biotechnology in relation to other technologies
  • 2. Application of Biotechnology in Animals
    • Introduction
    • Genetic engineering
      • Livestock improvement by genetic engineering
      • Disease control by genetic engineering
      • Limitations and precautions for genetic engineering
    • Transgenic animal technology
      • Cloning animals
      • Nuclear transfer technology
      • Nuclear bisection for cloning
      • Zona-free cloning method
      • Abnormalities in cloned animals
      • Cloning from embyonic cells
      • Cloning of rabbits
      • Cloning the rat
      • Cloning the horse
      • Cloning the cow
      • Cloning the dog
      • Cloning in primates
      • Retrovector-mediated production of transgenic animals
      • Episomal vector-mediated gene delivery
      • Sperm-mediated gene transfer
      • Lentiviral transduction of male germ-line stem cells
      • Lentiviral transgenesis
    • Transgenic pharmaceuticals
      • Proteins from the milk of transgenic animals
      • Advantages of milk as source of transgenic proteins
      • Therapeutic proteins from rabbit milk
      • Recombinant human antibodies from cows
      • Therapeutic proteins from goat milk
      • Chicken transgenesis for the production of biopharmaceuticals
      • Concluding remarks about production of recombinant proteins in animals
      • Companies involved in production of transgenic pharmaceuticals
    • Transgenic food products
      • Milking genetically modified cows
      • Transgenic fish
      • Cloned animals as sources of milk and meat
    • Animal feeds from transgenic plants
      • Transgenic modification of plants to increase nutritional value of animal feeds
    • Transgenic disease models
      • Technologies to create transgenic disease models
      • Gene manipulation techniques
      • Embryonic stem cells for gene targeting
      • Homologous recombination
      • Animal models of human diseases
      • Transgenic models for studying human drug metabolism and toxicity
      • The Human Genome Project and the role of transgenics
      • Genomic and proteomic analyses of transgenic animal models
      • Concern about health and welfare of transgenic animals
      • Safety of transgenic technology
      • Concluding remarks about use of transgenic animals
    • RNA interference technology
      • RNAi versus antisense
      • Applications of RNAi in animal biotechnology
    • Xenotransplantation
      • Pigs for xenotransplantation
      • Genetically engineered pigs for transplants
      • Risks of xenotransplantation
      • World Health Organization and xenotransplantation
      • Companies involved in xenotransplantation
    • Ethical aspects of animal biotechnology
  • 3. A Biotechnology Perspective of Animals Diseases
    • Introduction
    • Infections in animals
      • Viral infections
      • Avian influenza
      • Animal surveillance of influenza
      • Animal corona viruses and human SARS
      • Avian coronavirus
      • Canine parvovirus
      • Classical swine fever
      • Developing new treatments against FMDV
      • Equine infectious anemia
      • Foot-and-mouth disease
      • Porcine reproductive and respiratory syndrome virus
      • Rinderpest
      • Bacterial infections
      • Bovine tuberculosis
      • Mycoplasmal pneumonia
      • Protozoal infections
      • Neosporosis
      • Toxoplasmosis
      • Coccidiosis
      • Nematodes
      • Infections that cross the species barrier
      • Complications of bacterial infections and antibiotic use in animals
    • Transmissible spongiform encephalopathies (TSEs)
      • Scrapie
      • Bovine spongiform encephalopathy
      • Epidemiology of BSE
      • Human health implications of BSE
      • Breeding animals protected against BSE
      • TSE research
      • Prion gene haplotyping
      • Pharmacological approaches to TSE research
      • Molecular diagnostic approach to TSE research
      • RNAi for knockdown of the bovine prion gene
    • Chronic wasting disease
      • Chronic wasting disease in wildlife
      • Chronic wasting disease of the cattle in Sudan
      • Chronic wasting in dairy cows in the Netherlands
    • Genetic disorders in farm animals
    • Diseases of pet animals
      • Canine Anemia
      • Heart failure in dogs
      • Cancer in cats and dogs
      • Cancer clinical trials in dogs
      • Canine Comparative Oncology Genomics Consortium
    • Preventive veterinary medicine
      • Prevention of introduction of foreign animal diseases
      • Producing transgenic cattle resistant to BSE
    • Zoonotic diseases
      • Collaborative management of animal and human health
  • 4. Molecular Diagnostics in Animals
    • Introduction
    • Nucleic acid technologies
      • The polymerase chain reaction
      • Basic Principles of PCR
      • Target selection
      • Detection of amplified DNA
      • Real-time PCR systems
      • LightCycler PCR system
      • Molecular beacons
      • Applications of PCR in veterinary medicine
      • Fluorescent in situ hybridization
    • Immunodiagnostics
      • Enzyme-linked immunoassays
      • Bovine Gamma Interferon Test
      • Antigen diagnosis of trichinosis
      • Parachek for the diagnosis of Johne's disease
      • Antibodies for differentiation between vaccinated and infected animals
    • Biochip/microarray technology
      • Applications of microarrays in animal biotechnology
      • Cattlearray3800 for functional genomics
      • eSensor electrochemical biochip
    • Biosensors
      • Immunosensors
      • Biosensor for ovulation prediction in dairy cows
    • Flow cytometry for animal diagnostics
    • Molecular imaging in animals
    • Veterinary cytogenetics
    • Applications of molecular diagnostics in animals
      • Canine DNA testing
      • Diagnostic aids to selective breeding
      • Selection of desirable traits
      • Using genetic markers for improved milk production in dairy cattle
      • Application of bovine genomics for improving milk yield
      • Recognition of hereditary syndromes
      • Genetic markers in animals
      • SNP genotyping in animals
      • SNP genotyping for selective breeding of chicken
      • Animal identity and parentage analysis
      • Animal species identification in food
      • Diagnosis of infections
      • Bacterial infections
      • Diagnosis of viral infections
      • Molecular diagnosis of avian influenza
      • Diagnosis of parasitic infections
      • Detection of natural or bioterror threats to livestock
      • Molecular diagnosis of prion diseases
      • Bovine spongiform encephalopathy
      • Testing for BSE in living animals
      • Prions in urine
      • Diagnosis of chronic wasting disease in wildlife
      • Developing new tests for prion diseases
      • Differentiation among various types of TSEs
      • Protein cyclic amplification
      • Antibody tests for prion diseases
      • Scrapie genotyping
      • A real-time ultrasonic method for prion protein detection
      • Companies involved in developing molecular diagnostics for TSEs
      • Diagnosis of genetic disorders
      • Genetic screening of companion animals
      • Preimplantation genetic diagnosis
      • Diagnosis of cancer in animals
    • Diagnosis of food-borne pathogens
      • Introduction
      • Molecular diagnostic methods used in food-borne infections
      • Limitations of use of molecular probes in food analysis
      • Companies with technologies for food pathogen detection
    • Detection of chemicals in foods of animal origin
  • 5. Biotechnology-based Veterinary Medicine
    • Introduction
    • Biotechnology versus pharmaceutical products
    • Role of biotechnology in drug discovery and development
      • Cost of veterinary vs. human drug discovery and development
      • Advantages and disadvantages of testing biotech products in animal models
      • Biotechnolgoy-based antiparasitic drugs
    • Non-antibiotic strategies for control of infections in animals
      • Probiotics
      • Potential role for probiotics in the human gut
      • Potential role for probiotics in animals
      • Probiotic bacteria for control of pathogens in cattle
      • Nonantibiotic drugs for infections in animals
      • Immunomodulation as an alternative to antibiotics in infections
      • Cathelicidins: effector molecules of mammalian innate immunity
      • Bacteriophage therapy for antibiotic resistance
    • Biotechnology for treating tendon injuries
      • Use of growth factors to facilitate tendon injuries
    • Productivity enhancers
      • Bovine somatotropin for increasing milk production in dairy cows
      • Use of growth factors
    • Transgenic plant products for use in animals
    • Biotechnology-based vaccines
      • Modern vaccines without viral non-structural proteins
      • Vaccines for tick control
      • Plant-derived vaccines for use in animals
      • Genetically engineered vaccines
      • Application of nucleic acid vaccines in veterinary medicine
      • DNA vaccines
      • Genetic engineering of live rabies vaccines
      • DNA vaccine for tuberculosis
      • Potential for genetically engineered vaccines for Johne's disease
      • DNA vaccines for West Nile encephalitis
      • Gene-based vaccine for Marek''s disease
      • Genetically engineered vaccines for equine encephalitis
      • Vaccines against avian influenza
      • Vaccines against parasitic infections
      • Recombinant marker vaccines
      • Marker vaccines for foot-and-mouth disease
      • Marker vaccine for Newcastle disease
      • Vaccines for classical swine fever
      • Using RNAi to develop vaccines for viral infections in prawns
      • Nano-bead vaccine adjuvant
      • Companies developing biotechnology-based vaccines
    • Biotechnology in treatment of parasitic infections
    • Biotechnology in the treatment of CNS injuries in pet animals
      • Paraplegia due to acute spinal cord injury in dogs
    • RNAi for suppression prions in livestock
    • Cell Therapy
      • Umbilical cord blood stem cells
      • Application of stem cells in veterinary medicine
      • Use of stem cells to repair tendon injuries in horses
      • Stem cells for spinal cord injury in dogs
    • Gene therapy
      • Gene therapy vectors
      • Gene therapy by mitochondrial transfer
      • In utero gene therapy
      • Applications of gene therapy in veterinary medicine
      • Gene therapy for mucopolysaccharidosis VII in dogs
      • Gene therapy to increase disease resistance
      • Gene therapy for infections
      • Gene therapy for hematological disorders
      • Gene therapy for endocrine disorders
      • Gene therapy for arthritis
      • Cancer gene therapy
      • Brain tumors in cats and dogs
      • Breast cancer in dogs
      • Canine hemangiosarcoma
      • Canine melanoma
      • Canine soft tissue sarcoma
      • Melanoma in horses
  • 6. Research in Animal Biotechnology
    • Introduction
    • Research institutes
      • Animal and Natural Resources Institute (USDA)
      • Center for Animal Biotechnology at University of Melbourne (Australia)
      • CSIRO Livestock Industries
      • Danish Veterinary Institute
      • Friedrich-Loeffler-Institute
      • Indian Veterinary Research Institute
      • Institute for Animal Health of UK
      • Kimron Veterinary Institute
      • Korean National Livestock Research Institute
      • National Agricultural & Veterinary Biotechnology Center of Ireland
      • Swiss Federal Institute of Technology
      • Veterinary Laboratories Agency of UK
      • Veterinary Medical University of Vienna
    • Future prospects
      • Strategies for control of twining in cattle
      • Future developments of molecular diagnostics
      • Future of vaccine application in veterinary medicine
      • Promotion of innate immunity in animals
      • Identification of key parasite antigens for eliciting immune response
      • Virus-like particle vaccines for lasting immune response
      • Control of respiratory virus infections
      • Control and prevention of bioterrorism diseases in animals
      • Genetic control of disease resistance
      • Production of cattle lacking prion protein
      • Application of genetics and biotechnology to wildlife management
      • Future of animal genomics
  • 7. Animal Biotechnology Markets
    • Introduction
    • Markets for biotechnology-based products for animal healthcare
      • Markets for animal diagnostics
      • Test for bovine spongiform encephalopathy
    • Animal biotechnology markets according to therapeutic areas
    • Markets for biotechnology-based animal products for humans
      • Transgenic proteins
      • Market for xenotransplantation
    • Strategies for promoting use of animal biotechnology
      • Financial losses from death and disease in animals
      • Losses in farm animals
      • Losses in poultry
      • Losses in equine industry
      • The emerging role of pet owners
      • Improvement in cattle through application of biotechnology
      • Pig market
      • Cattle Market
      • Poultry market
      • Milk from genetically modified cows
      • Transgenic fish
      • Role of biotechnology in livestock performace enhancer market
      • Gene transfer technologies
      • Cost-benefit aspects of transgenic proteins
      • Lower costs of transgenic production
      • Lower costs of treatment
    • Unmet needs in animal biotechnology
    • Future opportunities for biotechnology in animal healthcare
      • Farm animals
      • Companion animals
  • 8. Regulatory issues
    • Introduction
    • Regulatory agencies for veterinary biotechnology in the US
    • FDA regulatory issues in agricultural biotechnology
    • Food safety evaluation of transgenic animals
      • Food from cloned animals
    • FDA investigation of drug transfer into eggs
    • Animal feed safety
      • Medicated feeds
    • Regulatory issues for production of transgenic proteins
    • Risks of animal biotechnology
    • FDA regulation of bovine products
    • Worldwide biotechnology regulatory and trade issues
  • 9. Companies Involved in Animal Biotechnology
    • Introduction
    • Biotechnology at top veterinary pharmaceutical companies
    • Profiles of selected companies
    • Collaborations
  • References
  • Tables
    • Table 1-1: Landmarks in the evolution of animal biotechnology in the 20th century
    • Table 1-2: Applications of genomics in livestock industry and veterinary medicine
    • Table 1-3: Applications of proteomics in livestock industry and veterinary medicine
    • Table 1-4: Selected animal genomics and proteomics databases (DB)
    • Table 1-5: Expression systems for production of recombinant biopharmaceuticals
    • Table 2-1: Recombinant proteins obtained from milk of transgenic animals
    • Table 2-2: Companies involved in the production of transgenic pharmaceuticals
    • Table 2-3: A comparison of gene knockout and transgenic techniques
    • Table 2-4: Examples of transgenic mouse models of non-neoplastic human diseases
    • Table 2-5: Companies involved in xenotransplantation
    • Table 3-1: Diseases of dairy cattle
    • Table 3-2: Causes of chronic wasting disease in animals
    • Table 4-1: Potential applications of microarrays in animal biotechnology
    • Table 4-2: Biosensor technologies with potential applications in molecular diagnostics
    • Table 4-3: Applications of molecular diagnostics in animals
    • Table 4-4: Viruses that can be detected by molecular diagnostics
    • Table 4-5: Testing for harmful prions in brain tissue from dead cattle
    • Table 4-6: Companies involved in developing molecular diagnostics for TSEs
    • Table 4-7: Pathogenic bacteria in food and targets for molecular diagnostic probes
    • Table 4-8: Companies involved in molecular diagnostics for food-borne infections
    • Table 5-1: Veterinary biotechnology products
    • Table 5-2: Pharmaceutical versus biotechnology products
    • Table 5-3: Nonantibiotic strategies for control of infections
    • Table 5-4: Experimental DNA vaccines tested in animals
    • Table 5-5: Companies developing biotechnology-based vaccines for animals
    • Table 6-1: Areas for future research applications of animal biotechnologies
    • Table 7-1: Worldwide markets for biotechnology-based products for farm animals: 2007-2017
    • Table 7-2: Worldwide markets for biotechnology-based products for pet animals: 2007-2017
    • Table 7-3: Biotechnology-based markets for animal healthcare according to regions: 2007-2017
    • Table 7-4: Biotechnology markets for farm animals according to therapeutic areas: 2007-2017
    • Table 7-5: Biotechnology markets for pet animals according to therapeutic areas: 2007-2017
    • Table 7-6: Worldwide markets for biotechnology-based animal products for humans: 2007-2017
    • Table 9-1: Biotechnology at top ten veterinary pharmaceutical companies
    • Table 9-2: Selected collaborations of companies in animal biotechnology
  • Figures
    • Figure 1-1: Relation of animal biotechnology to other technologies and human health
    • Figure 2-1: Nuclear transfer technology
    • Figure 2-2: Generation of transgenic animals by linker based sperm-mediated gene transfer
    • Figure 2-3: Production of therapeutic proteins in the milk of transgenic animals
    • Figure 7-1: Unmet needs in animal biotechnology